Neuroscientists identify a CRF-neuron "switch" in the brain's BNST region that, when activated, allows for significantly faster unlearning of fear responses.
A weeklong, high-intensity version of TMS may work nearly as well as the standard six-week treatment for depression. In a UCLA study, patients who received five sessions a day for five days ...
HELUS Pharma has rebranded and moved to Nasdaq, signaling a shift toward late-stage clinical development and commercial focus ...
Luvesilocin is a subcutaneously-administered, proprietary prodrug of the psilocybin-like compound 4-OH-DiPT designed to target the serotonin 2A receptor.
A new study explores exercise mimetics as novel therapeutics for depression by triggering muscle-to-brain signals that support mood regulation and resilience.
Other cells, such as glial cells, support the function of neurons. Neuroscience has often painted glial cells as the glue ...
Prolonged grief disorder affects around 1 in 20 people, and we're starting to understand the neuroscience behind it ...
Researchers found that a single 21.5mg dose of DMT reduced depression symptoms compared to placebo in patients with treatment ...
–Remain On Track to Initiate CYC-126's Phase 2 Proof-of-Concept (“POC”) Study in Treatment Resistant Depression (“TRD”) in the Second Half of 2026– ...
The presentation by Dr. Dirk Beher, Chief Executive Officer of FundaMental Pharma, will highlight the scientific foundation for lead candidate FMP374, the distinctive approach to modulating NMDAR, and ...
New research explores the risks and benefits of SSRI use during pregnancy, highlighting a link to gestational diabetes and ...
Free Malaysia Today on MSN
Too much screen time puts kids at higher risk of depression
New study involving 50,000 children finds that those who spend over four hours a day on screens face up to 61% higher risk of depression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results